Αποτελέσματα Αναζήτησης
19 Μαρ 2024 · Therapeutic Interventions in Heart Failure with Preserved Ejection Fraction. The goals of therapy for HFpEF are to reduce symptoms, improve quality of life, prevent disease progression, reduce hospitalizations, and effectively manage underlying comorbidities.
Heart failure with preserved ejection fraction (HFpEF), simply put, is when a person has a diagnosis of heart failure and their left ventricular ejection fraction (LVEF) is 50% or higher.
16 Μαρ 2024 · Heart failure with preserved ejection fraction (HFpEF), simply put, is when a person has a diagnosis of heart failure and their left ventricular ejection fraction (LVEF) is 50% or higher.
19 Απρ 2023 · Heart failure with preserved ejection fraction (HFpEF) is defined as signs and symptoms of HF with left ventricular EF (LVEF) ≥50%. Diagnosis and management of HFpEF needs multidisciplinary care involving primary care, cardiology, and HF specialists.
21 Μαρ 2023 · LEARNING OBJECTIVES. ⇒ To understand the definition and simplified pathophysiology of HFpEF. ⇒ To understand the appropriate diagnostic work- up for those patients with suspected HFpEF. ⇒ To understand contemporary pharmacological and non- pharmacological therapies for HFpEF.
22 Μαρ 2024 · Heart failure with preserved ejection fraction (HFpEF) is increasingly recognised and diagnosed in clinical practice, a trend driven by an ageing population and a rise in contributing comorbidities, such as obesity and diabetes. Representing at least half of all heart failure cases, HFpEF is recognised as a complex clinical syndrome.
Although patients with heart failure with preserved ejection fraction (HFpEF) (left ventricular ejection fraction ≥50%) comprise nearly half of those with chronic heart failure, evidence-based treatment options for this population have historically been limited.
